Who Owns Protalix Biotherapeutics Inc (PLX)? 13F Institutional Holders (Q2 2026)

PLX ranks #4512 out of 37696 tracked stocks by institutional interest, inside the more closely watched half of our coverage.

PLX is a disclosed holding of Jim Simons (Renaissance Technologies), one of the tracked superinvestors on AlphaSMO — it makes up 0.0% of that fund's own 13F portfolio.

104 institutions disclose a position in PLX, but none treat it as a major bet — even Main Street Financial Solutions, LLC, its most concentrated holder, allocates just 0.0% of its own portfolio to it.

State of Alaska, Department of Revenue has added to its PLX position for two straight quarters, increasing it by $13.0K to reach $60.0K today.

PLX is down 5.1% today, but institutions show net buying of $7.0M this quarter — a divergence between today's price move and the underlying institutional flow.

PLX posted net income of $18.9M over the trailing twelve months, and currently trades at a P/E of 10.8.

• Profitable — net income of $18.9M over the trailing twelve months
• Revenue grew 30.1% year over year
• Net income improved year over year, from $6.3M to $18.9M
• Operating cash flow was negative, using $12.0M in cash
• Current ratio of 2.51x — enough short-term assets to cover short-term liabilities
• Liabilities run 0.71x equity — within a conventional range